Technical Analysis for JAGX - Jaguar Animal Health, Inc.

Grade Last Price % Change Price Change
F 0.07 -0.86% 0.00
JAGX closed down 0.86 percent on Monday, March 18, 2024, on 56 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Mar 22
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish -0.86%
Outside Day Range Expansion -0.86%
Wide Bands Range Expansion -0.86%
Gapped Down Weakness -0.86%
Oversold Stochastic Weakness -0.86%
20 DMA Resistance Bearish -7.59%

   Recent Intraday Alerts

Alert Time
Down 5% about 13 hours ago
60 Minute Opening Range Breakdown about 14 hours ago
Down 3% about 14 hours ago
Down 2 % about 14 hours ago
Fell Below Previous Day's Low about 14 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Jaguar Animal Health, Inc. Description

Jaguar Animal Health, Inc., a development-stage animal health company, focuses on developing and commercializing gastrointestinal products for companion and production animals. The company's lead prescription drug product candidate includes Canalevia, a canine-specific formulation of Crofelemer for the treatment of CID and general acute watery diarrhea in dogs. It is also developing Crofelemer to treat acute colitis in horses and general acute watery diarrhea in cats; Neonorm, an enteric-coated tablet for scours in preweaned dairy calves, as well as other animal species, such as horses, goats, and sheep; and other product candidates, including Virend and NP-500. The company was founded in 2013 and is headquartered in San Francisco, California. Jaguar Animal Health, Inc. is a subsidiary of Napo Pharmaceuticals, Inc.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Gastrointestinal Animal Health Dog Gastroenterology Prescription Drugs Colitis Drug Products Diarrhea Gastrointestinal Tract Gastrointestinal Products

Is JAGX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.26
52 Week Low 0.0512
Average Volume 35,617,296
200-Day Moving Average 0.32
50-Day Moving Average 0.09
20-Day Moving Average 0.08
10-Day Moving Average 0.08
Average True Range 0.02
RSI (14) 43.18
ADX 19.15
+DI 30.41
-DI 24.17
Chandelier Exit (Long, 3 ATRs) 0.11
Chandelier Exit (Short, 3 ATRs) 0.10
Upper Bollinger Bands 0.12
Lower Bollinger Band 0.03
Percent B (%b) 0.42
BandWidth 114.29
MACD Line -0.01
MACD Signal Line -0.01
MACD Histogram 0.0
Fundamentals Value
Market Cap 3.52 Million
Num Shares 50.8 Million
EPS -0.87
Price-to-Earnings (P/E) Ratio -0.08
Price-to-Sales 0.46
Price-to-Book 3.12
PEG Ratio -0.02
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.08
Resistance 3 (R3) 0.08 0.08 0.08
Resistance 2 (R2) 0.08 0.07 0.08 0.08
Resistance 1 (R1) 0.07 0.07 0.07 0.07 0.08
Pivot Point 0.07 0.07 0.07 0.07 0.07
Support 1 (S1) 0.07 0.07 0.06 0.07 0.06
Support 2 (S2) 0.06 0.07 0.06 0.06
Support 3 (S3) 0.06 0.06 0.06
Support 4 (S4) 0.06